The Hospital Bet That Reframes The Intuitive Surgical Stock Story
While investors fixate on a slowdown in current procedures, hospitals are accelerating their investment in the company’s core…
How Much Upside Is Left in JNJ Stock?
While the market fixates on the STELARA patent cliff, the rest of the story is being missed. That…
Johnson & Johnson Is Becoming A Narrower Company Than You Bought
Management’s plain health care label has slipped out of the lead, and the business now on a separation…
Abbott Just Showed Its Growth Engine Has More Than One Cylinder
The healthcare giant’s stock jump was about more than an earnings beat, offering proof of a growth story…